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Abstract pl60 is a serine/threonine protein kinase that 
binds selectively to GTP-Rho and is activated by this binding. To 
identify its function, we transfected HeLa cells with wild type 
and mutants of pl60ROCK and examined morphology of the 
transfected cells. Transfection with wild type and mutants 
containing the kinase domain and the coiled-coil forming region 
induced focal adhesions and stress fibers, while no induction was 
observed with a kinase-defective mutant or a mutant containing 
only the kinase domain. Furthermore, Rho-induced formation of 
focal adhesions and stress fibers was inhibited by co-expression 
of a mutant defective in both kinase and Rho-binding activities. 
Rho, however, still induced an increase in F-actin content in these 
cells. These results suggest that pl60ROCK works downstream of 
Rho to induce formation of focal adhesions and that Rho-induced 
actin polymerization is mediated by other effector(s). 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The Rho family of small GTPases regulate cell shape and 
cell motility through reorganization of actin cytoskeletons 
[1,2]. In cultured fibroblasts and epithelial cells, Rho regulates 
the formation of focal adhesions and stress fibers to facilitate 
cell adhesion to the extracellular matrix via integrins [3,4]. 
Rho also regulates the avidity of integrins in platelets and 
lymphocytes to control their adhesion [5,6]. Rac, on the other 
hand, induces membrane ruffling with dot-like focal com-
plexes [7,8]. While several putative target proteins for Rho 
and Rac have been isolated, the biochemical mechanisms of 
the morphological changes induced by these GTPases remain 
unclarified (see [1,2] for review). One of the putative Rho 
target proteins is a serine/threonine protein kinase, 
pl60ROCK [9]. This kinase has a kinase domain in its amino-
terminus, a long amphipathic oc-helix capable of forming a 
coiled-coil structure in the middle, and a cysteine-rich zinc 
finger-like motif and a PH region in its carboxy-terminus. A 
homologue of pl60ROCK has been isolated and called either 
ROKa [10], Rho-kinase [11] or ROCK-II [12]. Recently, 
Leung et al. [13] reported that expression of ROKa induces 
focal adhesion- and stress fiber-like structures in cultured 
cells. Whether pl60ROCK elicits the same or a different pheno-
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Abbreviations: DMEM, Dulbecco's modified Eagle's medium; FCS, 
fetal calf serum; PBS, Dulbecco's phosphate buffered saline; PCR, 
polymerase chain reaction; PH, pleckstrin homology; pl60ROCK, a 
Rho-associated, coiled-coil forming protein kinase 
type is an intriguing question, because they show only 45-55% 
identity beside the kinase domain [12]. It also remains to be 
established whether these kinases work downstream of Rho in 
the cell, because two groups recently reported that both 
ROKa and pl60ROCK can interact with activated Rac in vitro 
and suggested that they may work downstream of Rac [14,15]. 
This point has not been clarified by the previous study [13]. 
We report here that pl60ROCK works downstream of Rho and 
not of Rac to mediate formation of focal adhesions and stress 
fibers. 
2. Materials and methods 
2.1. Materials and cell culture 
Anti-vinculin antibody (V-4505) and anti-RhoA polyclonal anti-
body (SC-179) were purchased from Sigma and Santa Cruz Biotech-
nology, respectively. Anti-Myc antibody (9E10) [16] was a gift from S. 
Nishikawa, Kyoto University. Antibody to pl60ROCK (C9) was raised 
in rabbits by immunizing with GST-fused recombinant protein of the 
C-terminal potion of pl60ROCK (aa 1096 to aa 1354) [17] and used. 
Plasmids of pEXV-Val14-RhoA and pEXV-Val12-Racl were provided 
by A. Hall. HeLa cells were grown in DMEM supplemented with 10% 
FCS. 
2.2. Expression constructs 
All constructs of pl60ROCK were tagged with a Myc epitope at the 
amino-terminus and expressed. 5'-HindY[\ fragment of pCMX-myc-
pl60ROCK [9] was ligated to a plasmid pBluescript SK+ digested with 
Hindlll to produce pBluescript-wryc-N. To construct pBluescript-m^c-
pl60, pBluescript-nyc-N was digested with BamHI-Notl, and a Bam-
Hl-Smal fragment of pCMX-myc pl60ROCK was ligated. A SaR-
BstXI fragment of pBluescript-myc-pl60 was inserted into pCAG 
vector [18] to produce pCAG-myc-pl60 (WT). A Xhol-EcoRV-Xhol 
linker was inserted into the 3'-Xhol site of pCAG-myc-pl60 (WT) to 
construct pCAG-m;yopl60myc~727 with three frame stop codons. 
Asp71&-Mscl, Aspin-Sphl, Aspl\%-Xho\, Aspl\%-Xba\ and Aspl\%-
Spel fragments were ligated to an Aspl 18-EcoKV fragment of pCAG-
mj<opl60myc~727 to generate pCAG-m^c-pl60Al, 2, 3, 4 and 5, respec-
tively. 
For site-directed mutagenesis of Lys105 to Ala, oligonucleotides 5'-
TGCTGCGGGATCCCAAATCGG-3', 5'-CAAATTTGCTGAGA-
AGCGCC ATGGC AT AT ACC- 3', 5'-GGTATATGCCATGGCGC-
TTCTCAGCAAATTTG-3' and 5'-GAACTACTTCTGCAGTATA-
GAATCG-3', designated primers A, B, C and D, corresponding to 
nucleotide sequences 50-71, 300-331, 300-331 and 526-550 of the 
coding region of pl60ROCK cDNA (underlined, the complementary 
sequences), respectively, were synthesized. PCR was performed with 
pCMX-myc-pl60ROCK as a template using primer pairs A and B, and 
C and D, separately. These products were combined, and PCR was 
performed using primers A and D. The product was digested with 
BamHl and Psil, and was inserted into a BamH\-Pstl fragment of 
pCMX-myc-pl60ROCK and pCMX-pl60ROCKI1009A [17] to make a kin-
ase defective mutant (KD) and a kinase defective, Rho-binding neg-
ative mutant (KD-IA), respectively. Fragments of pCMX-
pl60ROCK(KD) and pl60ROCK(KD-IA) were excised and inserted 
into pCAG vector to produce pCAG myc-KD and -KD-IA, respec-
tively. To generate pCAG-myc-C, PCR was performed with pCMX-
mj>c-pl60ROCK as a template using the forward primer 5'-CG-
0014-5793/97/S17.00 © 1997 Federation of European Biochemical Societies. All rights reserved. 
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GGGTACCGCCAGCAAAGAGAGTGATATTGAG-3' and the re-
verse primer 5'-TTGTCCAATTATGTCACACCACAG-3'. This 
product was digested with Aspll&Smal, and then ligated to an 
Aspl\%-EcoRW fragment of pCAG-m>'c-pl60myc-727. 
2.3. Transfection, immunofluorescence, Western blotting and immune 
complex kinase assay 
HeLa cells were plated on a coverglass at a density of 7.5 X104 cells 
per 3.5 cm dish and at a density of 1.5 X 105 cells per 6 cm dish for 
immunofluorescence and immunoprecipitation studies, respectively. 
After culture for one day, cells were transfected with plasmid DNA 
by the application of lipofectamine-DNA coprecipitates. At 4 h, 
DMEM containing 10% FCS was added and cells were cultured for 
another 12 h. Cells were then washed twice with PBS. Lysis of washed 
cells and immunoprecipitation of cell lysates with anti-Myc antibody 
were carried out as described previously [9]. 
Fixation, permeabilization and blocking for immunofluorescence 
were performed as described previously [19] except that cells for 
anti-vinculin staining were simultaneously treated with 4% formalde-
hyde and 0.1% Triton X-100 in Ca2+ and Mg2+-free PBS. Cells were 
first incubated with either anti-Myc (9E10) antibody (17 mg/ml) 
(1:500 in blotto), anti-vinculin antibody (1:100 in blotto), anti-
RhoA antibody (1:50 in blotto), anti-pl60ROCK C9 (1:100 in blotto) 
or combinations of anti-vinculin and either anti-Rho or anti-pl60 
antibodies. Anti-Myc (9E10) and anti-vinculin antibodies were de-
tected with FITC-conjugated anti-mouse IgG. Rhodamine-conjugated 
or Cy2-conjugated anti-rabbit IgG were used to detect signals of anti-
Rho and anti-pl60 antibodies. For F-actin staining, rhodamine-con-
jugated phalloidin (Molecular Probes) was added after incubation 
with the second antibody. Cells were photographed on a Zeiss Axio-
phot fluorescence microscope or were analyzed at 0.36 urn optical 
sections on a Bio-Rad MRC-1024 Confocal Imaging System and 
built-up images were constructed. 
3. Results and discussion 
3.1. Expression ofpl60ROCK and its mutants 
pl60ROCK is a multi-domain protein containing a kinase 
domain, a coiled-coil forming a-helix region, the Rho-binding 
Ydomain, a PH and a cysteine-rich regions. To identify its 
role in Rho-mediated cellular processes and to identify the 
function of each domain, we expressed wild type (WT) as 
well as mutants of this protein. The mutants used in this study 
were five truncation mutants having the above domains de-
leted from the C-terminus (A1-A5), a C-terminal fragment 
containing the PH and cysteine-rich regions only (C), and 
full length proteins with a point mutation in the kinase do-
main (KD) and with point mutations both in the kinase and 
the Rho-binding domains (KD-IA) (Fig. 1A). Plasmids carry-
ing these constructs were transfected into HeLa cells, and 
lysates of transfected cells were used for immunoprecipitation 
and immunoblotting analysis. As shown in Fig. IB, proteins 
of the expected sizes were recovered with each transfection. 
Expression levels of the mutants A2 and KD-IA were signifi-
cantly lower than the others. Immunoprecipitates were then 
subjected to the kinase assay with histone as a substrate (Fig. 
1C). Phosphorylation was observed in WT protein as well as 
the A1-A4 mutants. The A5 mutant showed little histone phos-
phorylation, although it gave an autophosphorylation band. 
Apparently no phosphorylation was observed in the C or the 
KD-IA mutant. It was neither detected in the KD mutant 
(data not shown). 
3.2. Induction of focal adhesion- and stress fiber-like structures 
by />/(50ROCK and its mutants 
We next identified cells expressing these proteins by the 
staining of Myc epitope tagged to the N-terminus of each 
protein, and characterized the morphology of each transfec-
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Fig. 1. Diagrammatic representation of pl60ROCK mutants (A), and 
immunoblotting (B) and immune complex kinase assay (C) of ex-
pressed proteins. A: Structural domains of pl60ROCK are schemati-
cally represented at the top and the eight mutants are represented 
by the thick lines below. Numbers indicate amino acid residues of 
the amino- and carboxyl-termini of each mutant. The positions of 
point mutations are indicated by X. B and C: Expression of 
pl60ROCK mutants in HeLa cells. Expressed proteins in HeLa cells 
were immunoprecipitated with anti-Myc antibody (9E10), and im-
munoprecipitates were subjected to Western blotting (B) and to a 
phosphorylation reaction (C) as described [9]. Lane 1, WT; lane 2, 
Al; lane 3, A2; lane 4, A3; lane 5, A4; lane 6, A5; lane 7, KD-IA; 
lane 8, C. In B, cell lysates from one 6 cm dish were used except 
for analysis of the mutants A2 and KD-IA, which used lysates from 
six dishes. Positions of molecular weight markers are indicated at 
the right margin. In C, one tenth each of lysates from seven 6 cm 
dishes were used. Arrowheads indicate autophosphorylated bands of 
each mutant. M represents cells transfected with a vector alone. 
tant. Transfected cells were then subjected to double staining 
for vinculin and actin. The characteristic phenotype of each 
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Fig. 2. Morphology of HeLa cells overexpressing pl60ROCK mutants. HeLa cells were transfected with 1 iig of vector alone (A and B), or vec-
tor carrying WT (C and D), Al (E and F), A2 (G and H), A3 (I and J), A4 (K and L) or A5 (M and N) mutant of pl60ROCK. After 16 h of in-
cubation, cells were double-stained with rhodamine-phalloidin (left panels; A, C, E, G, I, K and M) and with anti-vinculin antibody (right pan-
els; B, D, F, H, J, L and N). Images built up from optical sections by a confocal imaging system are shown. Scale bar, 20 urn. 
transfectant is shown in Fig. 2. Expression of WT resulted in 
elongated rectangular to polygonal cell shapes with pointed 
edges (Fig. 2C,D). Thin actin bundles were formed and termi-
nated at the pointed edges. Punctate vinculin staining was 
observed at the termini of the actin bundles. Upon expression 
of Al mutant, actin bundles spanning the cells became thick 
and increased in number. Consistently, vinculin staining in-
creased in size and number and became more dense (Fig. 
2E,F). Essentially the same morphology was observed in cells 
transfected with A2 mutant (Fig. 2G,H), indicating that Rho 
binding was not required for induction of this change. In cells 
expressing A3 mutant, vinculin staining became more dense 
and larger, and some of them were located within the cells 
or concentrated at one edge of the cells (Fig. 2I,J). Actin 
bundles thicker and shorter than those found in the Al and 
A2-transfected cells were seen between the vinculin-containing 
structures (Fig. 2I,J). Similar changes were found in cells ex-
pressing A4 (Fig. 2K,L). In contrast to these findings, no sig-
nificant morphological changes were found in cells expressing 
A5, the kinase domain alone (Fig. 2M,N). Expression of the 
kinase-defective mutant, KD, also failed to induce the pheno-
typic change (data not shown). 
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3.3. A dominant negative form ofpl60ROCK blocks bundles extending between these structures. They also sug-
Rho-induced formation of focal adhesions and stress fibers gested that both kinase activity and a part of the coiled-coil 
but not Rac-induced membrane ruffling forming region are required for this induction. The observed 
The above results thus demonstrated that expression of phenotype appeared similar to that reported for ROKoc in the 
pl60ROCK can induce focal adhesion-like structures as evi- previous study [13]. However, these phenotypes were not ex-
denced by vinculin accumulation and stress fiber-like actin actly the same as that induced by activated Rho [13] (Figs. 2 
Fig. 3. Inhibition of Rho-induced formation of focal adhesions by co-expression of KD-IA mutant of pl60ROCK. HeLa cells were transfected ei-
ther with 0.2 |xg of pEXV-Val14-RhoA or with 0.2 ug of pEXV-Val12-Racl alone (A and B for Rho, G and H for Rac) or together with 2 ug 
of pCAG-KD-IA mutant of pl60ROCK (C-F for co-transfection with Rho, I and J for co-transfection with Rac). After 16 h of incubation, cells 
were double-stained either with rhodamine phalloidin (A and G) and anti-vinculin (B and H), with anti-RhoA antibody (C) and anti-vinculin 
antibody (D), with anti-RhoA antibody (E) and rhodamine phalloidin (F), with anti-pl60 antibody and rhodamine phalloidin (I) or with anti-
pl60 antibody and anti-vinculin antibody (J). Arrows indicate cells expressing Val14-RhoA (A-F) and cells expressing the KD-IA mutant (I and 
J). Photographs taken on a fluorescence microscope (A-F) and built-up images by a confocal imaging system (G-J) are shown. Scale bar, 20 
um. 
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Fig. 3. {continued). 
and 3). We, therefore, examined the involvement of pl60ROCK 
in Rho-induced focal adhesion and stress fiber formation by 
co-transfecting HeLa cells with Val14-RhoA and KD-IA, a 
kinase-defective, Rho-binding negative mutant. Transfection 
with Val14-RhoA alone strongly induced both stress fibers 
and focal adhesions (Fig. 3A,B). Co-expression of the KD-
IA mutant of pl60ROCK suppressed induction of focal adhe-
sions as shown in Fig. 3C,D. Stress fibers were not found, but 
a generalized increase in the amount of F-actin was observed 
in these cells (Fig. 3E,F). Co-expression of the C mutant also 
suppressed Val14-RhoA-induced formation of focal adhesions 
and stress fibers (data not shown). We next examined if the 
KD-IA and C mutants inhibit a morphological phenotype 
evoked by Val12-Rac. Transfection of Val12-Rac alone 
strongly induced formation of membrane ruffling and dot-
like focal complexes with concomitant Rho-dependent forma-
tion of stress fibers as described before [7] (Fig. 3G,H). Co-
expression with the KD-IA mutant did not inhibit the forma-
tion of the former structures induced by activated Rac, but 
did inhibit the Rho-dependent latter structures (Fig. 3I,J). A 
similar effect was found with co-expression of the C mutant 
(data not shown). These results strongly suggest that 
pl60ROCK selectively works downstream of Rho to induce 
focal adhesions and stress fibers in the cell. Whether ROKcc 
exerts the same function in the cell remains to be tested. In-
terestingly, Val14-RhoA still increased F-actin content in these 
cells, suggesting that Rho-induced actin polymerization is 
mediated by a different effector. This is consistent with pre-
vious studies showing that a kinase inhibitor, staurosporine, 
inhibits focal adhesion formation without affecting the F-actin 
increase induced by Rho, and that blocking of actin polymer-
RhoGTP 
p l 6 0ROCK X 
j Actin Polymerization 
Integrin Activation I 
& Ligation j 
, F-Actin 
Integrin Clustering 
& Actin Bundling 
I 
Focal Adhesions 
& Stress Fibers 
Fig. 4. Proposed action of pl60ROCK in Rho-mediated formation of 
focal adhesions and stress fibers. 
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ization with cytochalasins could not inhibit Rho-mediated cell 
adhesion and focal adhesion formation [6,8]. We have recently 
isolated a novel Rho-binding protein, which induces actin 
polymerization in transfected cells (Watanabe, N . and Naru-
miya, S., unpublished observation). 
Focal adhesion formation requires integrin activation, its 
ligation with ligands and clustering of ligated integrins. Bun-
dling of F-actin as stress fibers may accompany integrin clus-
tering [20]. Based on the present findings, we postulate the 
role of p l 6 0 R O C K in Rho-mediated actions as depicted in 
Fig. 4. Clustering of ligated integrins and bundling of F-actin 
may be induced by a pl60-mediated increase in myosin con-
tractility as reported for Rho-kinase by Kimura et al. [21]. It 
is of interest that expression of the C mutant alone can induce 
dominant negative effects on Rho , indicating that this trunca-
tion product competes with endogenous p l 6 0 R O C K for the 
binding at targeting sites. These issues will be addressed in 
future studies by identifying interacting molecules and sub-
s t ra te^) of this kinase. 
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